Peritoneal dialysate effluent during peritonitis induces human cardiomyocyte apoptosis by regulating the expression of GATA-4 and Bcl-2 families

Journal of Cellular Physiology

Volumn 226, Issue 1, 2011, Pages 94-102

  Wang, Hsin Hui ^a,b   Li, Ping Chun ^c   Huang, Hsiao Ju ^c   Lee, Tzong Yann ^d,e   Lin, Ching Yuang ^c,f  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d EN CHU KONG HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLSERINE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; TRANSCRIPTION FACTOR GATA 4;

ADULT; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; DIALYSATE; DNA DAMAGE; DNA FRAGMENTATION; EFFLUENT TOXICITY; FEMALE; GENETIC ANALYSIS; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MALE; MORTALITY; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; ASCITIC FLUID; BCL-2-ASSOCIATED X PROTEIN; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENES, BCL-2; HUMANS; MALE; MIDDLE AGED; MULTIGENE FAMILY; MYOCYTES, CARDIAC; PERITONEAL DIALYSIS; PERITONITIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 78049275399     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22309     Document Type: Article

References (44)

1. Ancey C, Corbi P, Froger J, Delwail A, Wijdenes J, Gascan H, Potreau D, Lecron JC. 2002. Secretion of IL-6, IL-11 and LIF by human cardiomyocytes in primary culture. Cytokine 18: 199-205.
2. Aries A, Paradis P, Lefebvre C, Schwartz RJ, Nemer M. 2004. Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc Natl Acad Sci USA 101: 6975-6980.
3. Aslam N, Bernardini J, Fried L, Burr R, Piraino B. 2006. Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients. Clin J Am Soc Nephrol 1: 1226-1233.
4. Barroso-Aranda J, Schmid-Schonbein GW, Zweifach BW, Mathison JC. 1991. Polymorphonuclear neutrophil contribution to induced tolerance to bacterial lipopolysaccharide. Circ Res 69: 1196-1206.
5. Bender FH, Bernardini J, Piraino B. 2006. Prevention of infectious complications in peritoneal dialysis: Best demonstrated practices. Kidney Int 103(Suppl): S44-S54.
6. Bishopric NH, Andreka P, Slepak T, Webster KA. 2001. Molecular mechanisms of apoptosis in the cardiac myocyte. Curr Opin Pharmacol 1: 141-150.
7. Chang KC, Barth AS, Sasano T, Kizana E, Kashiwakura Y, Zhang Y, Brian Foster D, Marbán E. 2008. CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart. Proc Natl Acad Sci USA 105: 4477-4482.
8. Chen Q, Gong B, Mahmoud-Ahmed AS, Zhou A, Hsi ED, Hussein M, Almasan A. 2001a. Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma. Blood 98: 2183-2192.
9. Chen Z, Chua CC, Ho YS, Hamdy RC, Chua BH. 2001b. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol 280: H2313-H2320.
10. Cory S, Adams JM. 2002. The Bcl2 family: Regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656.
11. Digenis GE, Abraham G, Savin E, Blake P, Dombros N, Sombolos K, Vas S, Mathews R, Oreopoulos DG. 1990. Peritonitis-related deaths in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int 10: 45-47.
12. Firanek CA, Vonesh EF, Korbet SM. 1991. Patient and technique survival among an urban population of peritoneal dialysis patients: An 8-year experience. Am J Kidney Dis 18: 91-96.
13. Foo RS, Mani K, Kitsis RN. 2005. Death begets failure in the heart. J Clin Invest 115: 565-571.
14. Fried LF, Bernardini J, Johnston JR, Piraino B. 1996. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 7: 2176-2182.
15. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. 2004. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305.
16. Haudek SB, Taffet GE, Schneider MD, Mann DL. 2007. TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J Clin Invest 117: 2692-2701.
17. Haunstetter A, Izumo S. 1998. Apoptosis: Basic mechanisms and implications for cardiovascular disease. Circ Res 82: 1111-1129.
18. Ishani A, Collins AJ, Herzog CA, Foley RN. 2005. Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 study. Kidney Int 68: 311-318.
19. Jarpe MB, Widmann C, Knall C, Schlesinger TK, Gibson S, Yujiri T, Fanger GR, Gelfand EW, Johnson GL. 1998. Anti-apoptotic versus pro-apoptotic signal transduction: Checkpoints and stop signs along the road to death. Oncogene 17: 1475-1482.
20. Kim Y, Ma AG, Kitta K, Fitch SN, Ikeda T, Ihara Y, Simon AR, Evans T, Suzuki YJ. 2003. Anthracycline-induced suppression of GATA-4 transcription factor: Implication in the regulation of cardiac myocyte apoptosis. Mol Pharmacol 63: 368-377.
21. Kitta K, Clement SA, Remeika J, Blumberg JB, Suzuki YJ. 2001. Endothelin-1 induces phosphorylation of GATA-4 transcription factor in the HL-1 atrial-muscle cell line. Biochem J 359: 375-380.
22. Kitta K, Day RM, Kim Y, Torregroza I, Evans T, Suzuki YJ. 2003. Hepatocyte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells. J Biol Chem 278: 4705-4712.
23. Kobayashi S, Lackey T, Huang Y, Bisping E, Pu WT, Boxer LM, Liang Q. 2006. Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo. FASEB J 20: 800-802.
24. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC. 2000. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 35: 644-652.
25. Lupo A, Tarchini R, Carcarini G, Catizone L, Cocchi R, De Vecchi A, Viglino G, Salomone M, Segoloni G, Giangrande A. 1994. Long-term outcome in continuous ambulatory peritoneal dialysis: A 10-year-survey by the Italian Cooperative Peritoneal Dialysis Study Group. Am J Kidney Dis 24: 826-837.
26. Madorin WS, Cepinskas G, Kvietys PR. 2001. Peritonitis induces rat cardiac myocytes to promote polymorphonuclear leukocyte emigration and activate endothelial cells: Effect of lipopolysaccharide pretreatment. Crit Care Med 29: 1774-1779.
27. Maiorca R, Cancarini GC, Brunori G, Camerini C, Manili L. 1993. Morbidity and mortality of CAPD and hemodialysis. Kidney Int Suppl 40: S4-S15.
28. Mann DL. 1999. Inflammatory mediators in heart failure: Homogeneity through heterogeneity. Lancet 353: 1812-1813.
29. Morimoto T, Hasegawa K, Kaburagi S, Kakita T, Wada H, Yanazume T, Sasayama S. 2000. Phosphorylation of GATA-4 is involved in alpha 1-adrenergic agonist-responsive transcription of the endothelin-1 gene in cardiac myocytes. J Biol Chem 275: 13721-13726.
30. Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD, Dal Bello B, Semigran MJ, Bielsa-Masdeu A, Dec GW, Israels S, Ballester M, Virmani R, Saxena S, Kharbanda S. 1999. Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA 96: 8144-8149.
31. Natanson C, Danner RL, Elin RJ, Hosseini JM, Peart KW, Banks SM, MacVittie TJ, Walker RI, Parrillo JE. 1989. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest 83: 243-251.
32. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. 1997. Apoptosis in the failing human heart. N Engl J Med 336: 1131-1141.
33. Parfrey PS, Foley RN. 1999. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 10: 1606-1615.
34. Pérez Fontan M, Rodríguez-Carmona A, García-Naveiro R, Rosales M, Villaverde P, Valdés F. 2005. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 25: 274-284.
35. Piraino B. 1998. Peritonitis as a complication of peritoneal dialysis. J Am Soc Nephrol 9: 1956-1964.
36. Ramana KV, Willis MS, White MD, Horton JW, DiMaio JM, Srivastava D, Bhatnagar A, Srivastava SK. 2006. Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition. Circulation 114: 1838-1846.
37. Schiffrin EL, Lipman ML, Mann JF. 2007. Chronic kidney disease: Effects on the cardiovascular system. Circulation 116: 85-97.
38. Shan K, Lincoff AM, Young JB. 1996. Anthracycline-induced cardiotoxicity. Ann Intern Med 125: 47-58.
39. Sibelius U, Grandel U, Buerke M, Mueller D, Kiss L, Kraemer HJ, Braun-Dullaeus R, Haberbosch W, Seeger W, Grimminger F. 2000. Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: Role of thromboxane generation. Circulation 101: 78-85.
40. Silberberg JS, Barre PE, Prichard SS, Sniderman AD. 1989. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36: 286-290.
41. Suzuki YJ, Evans T. 2004. Regulation of cardiac myocyte apoptosis by the GATA-4 transcription factor. Life Sci 74: 1829-1838.
42. U.S. Renal Data System. 2008. USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
43. Wang HH, Lin CY. 2005. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: Implications for the Type I/Type II T-cell immune response. Am J Kidney Dis 46: 328-338.
44. Wang HH, Lee TY, Lin CY. 2008. Integrins mediate adherence and migration of T lymphocytes on human peritoneal mesothelial cells. Kidney Int 74: 808-816.